Search by Drug Name or NDC

    NDC 61958-1504-01 Sovaldi 150 mg/1 Details

    Sovaldi 150 mg/1

    Sovaldi is a ORAL PELLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Gilead Sciences, Inc.. The primary component is SOFOSBUVIR.

    Product Information

    NDC 61958-1504
    Product ID 61958-1504_d0b160ff-8146-4893-86f0-1925fcd67ad9
    Associated GPIs 12353080003015
    GCN Sequence Number 080164
    GCN Sequence Number Description sofosbuvir PELET PACK 150 MG ORAL
    HIC3 W5Y
    HIC3 Description HEP C VIRUS,NUCLEOTIDE ANALOG NS5B POLYMERASE INH
    GCN 46871
    HICL Sequence Number 040795
    HICL Sequence Number Description SOFOSBUVIR
    Brand/Generic Brand
    Proprietary Name Sovaldi
    Proprietary Name Suffix n/a
    Non-Proprietary Name SOFOSBUVIR
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form PELLET
    Route ORAL
    Active Ingredient Strength 150
    Active Ingredient Units mg/1
    Substance Name SOFOSBUVIR
    Labeler Name Gilead Sciences, Inc.
    Pharmaceutical Class Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC], RNA Replicase Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA212480
    Listing Certified Through 2024-12-31

    Package

    NDC 61958-1504-01 (61958150401)

    NDC Package Code 61958-1504-1
    Billing NDC 61958150401
    Package 60 PELLET in 1 PACKET (61958-1504-1)
    Marketing Start Date 2019-08-28
    NDC Exclude Flag N
    Pricing Information N/A